{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T02:15:46Z","timestamp":1779329746009,"version":"3.51.4"},"reference-count":43,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T00:00:00Z","timestamp":1763424000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The fibrinogen-to-albumin ratio (FAR) has emerged as a promising inflammatory marker, but its relationship with rheumatoid arthritis (RA) disease activity remains unclear. This study sought to elucidate the association between FAR and RA disease activity and to assess its potential for identifying high disease activity states.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a cross-sectional study of 1,191 consecutive RA inpatients at Xingtai People\u2019s Hospital from March 2022 to December 2024. FAR was calculated as fibrinogen (g\/L) divided by albumin (g\/L). Disease activity was assessed using the 28-joint Disease Activity Score (DAS28) based on C-reactive protein (DAS28-CRP) and erythrocyte sedimentation rate (DAS28-ESR). Multiple linear regression and generalized additive models were employed to examine the association of FAR with disease activity. Receiver operating characteristic (ROC) analysis evaluated FAR\u2019s discriminatory performance for high disease activity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>After exclusions, 981 patients (mean age, 57.7 years; 77.9% female) were included; 95.6% had moderate-to-high disease activity. A significant nonlinear association between FAR and disease activity was detected, with a saturation threshold at FAR = 0.14. Below this threshold, FAR was strongly and positively associated with DAS28-ESR [\u03b2 = 15.21; 95% confidence interval (CI), 13.01\u201317.42] and DAS28-CRP (\u03b2 = 13.07; 95% CI, 11.07\u201315.07). Above the threshold, associations were substantially attenuated and not statistically significant (DAS28-ESR: \u03b2 = 2.19; 95% CI, \u22121.53\u20135.92; DAS28-CRP: \u03b2 = 3.37; 95% CI, \u22120.01\u20136.74). Furthermore, FAR demonstrated good discriminatory ability between high and moderate disease activity, with area under the curve (AUC) values of 0.80 for DAS28-ESR and 0.81 for DAS28-CRP.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study identified a nonlinear relationship between FAR and RA disease activity in inpatients with predominantly moderate-to-high disease activity, characterized by a saturation threshold effect. FAR showed good discriminatory ability for distinguishing high from moderate disease activity. These findings suggest that FAR may serve as a promising and readily accessible inflammatory marker to complement existing assessments of disease activity. However, multicenter validation is warranted.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2025.1670731","type":"journal-article","created":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T06:22:55Z","timestamp":1763446975000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["The potential value of fibrinogen-to-albumin ratio in assessing disease activity in rheumatoid arthritis"],"prefix":"10.3389","volume":"16","author":[{"given":"Xiaoli","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingfang","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lina","family":"Leng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaorong","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinfeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lianju","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuhua","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,11,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(23)01525-8","article-title":"Rheumatoid arthritis","volume":"402","author":"Di Matteo","year":"2023","journal-title":"Lancet"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-020-00816-x","article-title":"The immunology of rheumatoid arthritis","volume":"22","author":"Weyand","year":"2021","journal-title":"Nat Immunol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1186\/s13287-023-03473-7","article-title":"Rheumatoid arthritis: the old issue, the new therapeutic approach","volume":"14","author":"Babaahmadi","year":"2023","journal-title":"Stem Cell Res Ther"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2018.10.005","article-title":"Update on the epidemiology, risk factors, and disease outcomes of rheumatoid arthritis","volume":"32","author":"van der Woude","year":"2018","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/S2665-9913(23)00211-4","article-title":"Global, regional, and national burden of rheumatoid arthritis, 1990-2020, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021","volume":"5","year":"2023","journal-title":"Lancet Rheumatol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3390\/cells9040880","article-title":"Update on the pathomechanism, diagnosis, and treatment options for rheumatoid arthritis","volume":"9","author":"Lin","year":"2020","journal-title":"Cells"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2018.00185","article-title":"The utility and limitations of CRP, ESR and DAS28-CRP in appraising disease activity in rheumatoid arthritis","volume":"5","author":"Orr","year":"2018","journal-title":"Front Med (Lausanne)"},{"key":"B8","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1093\/rheumatology\/kex036","article-title":"Diagnostic test accuracy of ultrasound for synovitis in rheumatoid arthritis: systematic review and meta-analysis","volume":"57","author":"Takase-Minegishi","year":"2018","journal-title":"Rheumatol (Oxford)"},{"key":"B9","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s00281-011-0290-8","article-title":"Fibrinogen as a key regulator of inflammation in disease","volume":"34","author":"Davalos","year":"2012","journal-title":"Semin Immunopathol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2011.05.001","article-title":"Fibrinogen and cardiovascular disease: genetics and biomarkers","volume":"25","author":"Tousoulis","year":"2011","journal-title":"Blood Rev"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.85.9.6779","article-title":"Increased fibrinogen production in type 2 diabetic patients without detectable vascular complications: correlation with plasma glucagon concentrations","volume":"85","author":"Barazzoni","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1111\/j.0894-0959.2004.17603.x","article-title":"Serum albumin: relationship to inflammation and nutrition","volume":"17","author":"Don","year":"2004","journal-title":"Semin Dial"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1002\/clc.23981","article-title":"Fibrinogen-albumin ratio predicting major adverse cardiovascular outcomes post-percutaneous coronary intervention: A systematic review and exploratory meta-analysis","volume":"46","author":"Desai","year":"2023","journal-title":"Clin Cardiol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-022-02445-w","article-title":"The Prognostic value of the Fibrinogen to pre-albumin ratio in Malignant tumors of the digestive system: a systematic review and meta-analysis","volume":"22","author":"Li","year":"2022","journal-title":"Cancer Cell Int"},{"key":"B15","doi-asserted-by":"publisher","first-page":"e24621","DOI":"10.1002\/jcla.24621","article-title":"The predictive value of fibrinogen-to-albumin ratio in the active, severe active, and poor prognosis of systemic lupus erythematosus: A single-center retrospective study","volume":"36","author":"Dai","year":"2022","journal-title":"J Clin Lab Anal"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2020.02.029","article-title":"The role of fibrinogen to albumin ratio in ankylosing spondylitis: Correlation with disease activity","volume":"505","author":"Liu","year":"2020","journal-title":"Clin Chim Acta"},{"key":"B17","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1186\/s12891-022-05797-6","article-title":"The potential value of fibrinogen to albumin ratio (FAR) in the assessment of inflammation in spondyloarthritis","volume":"23","author":"Ding","year":"2022","journal-title":"BMC Musculoskelet Disord"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2025.1460975","article-title":"Fibrinogen-to-albumin ratio: a new biomarker to identify inflammatory bowel disease in active stage","volume":"12","author":"Chen","year":"2025","journal-title":"Front Med (Lausanne)"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1002\/art.27584","article-title":"2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative","volume":"62","author":"Aletaha","year":"2010","journal-title":"Arthritis Rheum"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1506115","article-title":"A multicenter observational study of incretin-based drugs and heart failure","volume":"374","author":"Filion","year":"2016","journal-title":"N Engl J Med"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2012410","article-title":"Observational study of hydroxychloroquine in hospitalized patients with covid-19","volume":"382","author":"Geleris","year":"2020","journal-title":"N Engl J Med"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1111\/1756-185X.12698","article-title":"Comparison of the disease activity score using the erythrocyte sedimentation rate and C-reactive protein levels in Koreans with rheumatoid arthritis","volume":"19","author":"Son","year":"2016","journal-title":"Int J Rheum Dis"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)31472-1","article-title":"Pathogenetic insights from the treatment of rheumatoid arthritis","volume":"389","author":"McInnes","year":"2017","journal-title":"Lancet"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2019.10.009","article-title":"Correlation between albumin to fibrinogen ratio, C-reactive protein to albumin ratio and Th17 cells in patients with rheumatoid arthritis","volume":"500","author":"He","year":"2020","journal-title":"Clin Chim Acta"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.2147\/OARRR.S268668","article-title":"Value of albumin-fibrinogen ratio and CRP-albumin ratio as predictor marker of disease activity in Egyptian RA patients, correlated with musculoskeletal sonography","volume":"12","author":"Afifi","year":"2020","journal-title":"Open Access Rheumatol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2018.07.007","article-title":"Two new inflammatory markers associated with disease activity score-28 in patients with rheumatoid arthritis: Albumin to fibrinogen ratio and C-reactive protein to albumin ratio","volume":"62","author":"Yang","year":"2018","journal-title":"Int Immunopharmacol"},{"key":"B27","article-title":"Comparative usefulness of C-reactive protein and erythrocyte sedimentation rate in patients with rheumatoid arthritis","volume":"24","author":"Wolfe","year":"1997","journal-title":"J Rheumatol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.arth.2016.06.027","article-title":"Characterizing the acute phase response in healthy patients following total joint arthroplasty: predictable and consistent","volume":"32","author":"Oelsner","year":"2017","journal-title":"J Arthroplasty"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3390\/biom11071036","article-title":"Fibrinogen and a triad of thrombosis, inflammation, and the renin-angiotensin system in premature coronary artery disease in women: A new insight into sex-related differences in the pathogenesis of the disease","volume":"11","author":"Kryczka","year":"2021","journal-title":"Biomolecules"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1053\/euhj.1999.2207","article-title":"Genetics of inflammation and risk of coronary artery disease: the central role of interleukin-6","volume":"21","author":"Woods","year":"2000","journal-title":"Eur Heart J"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/s0950-3536(89)80053-8","article-title":"Control of plasma fibrinogen levels","volume":"2","author":"Green","year":"1989","journal-title":"Baillieres Clin Haematol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.2001.tb03523.x","article-title":"Recognition of fibrinogen by leukocyte integrins","volume":"936","author":"Ugarova","year":"2001","journal-title":"Ann N Y Acad Sci"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1021\/bi034057k","article-title":"Sequence gamma 377-395(P2), but not gamma 190-202(P1), is the binding site for the alpha MI-domain of integrin alpha M beta 2 in the gamma C-domain of fibrinogen","volume":"42","author":"Ugarova","year":"2003","journal-title":"Biochemistry"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.166.3.2002","article-title":"Fibrinogen promotes neutrophil activation and delays apoptosis","volume":"166","author":"Rubel","year":"2001","journal-title":"J Immunol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.161.3.1462","article-title":"Fibrinogen activates NF-kappa B transcription factors in mononuclear phagocytes","volume":"161","author":"Sitrin","year":"1998","journal-title":"J Immunol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.167.5.2887","article-title":"Fibrinogen stimulates macrophage chemokine secretion through toll-like receptor 4","volume":"167","author":"Smiley","year":"2001","journal-title":"J Immunol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1002\/eji.200323512","article-title":"Fibrinogen-CD11b\/CD18 interaction activates the NF-kappa B pathway and delays apoptosis in human neutrophils","volume":"33","author":"Rubel","year":"2003","journal-title":"Eur J Immunol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1152\/ajpcell.00177.2004","article-title":"Primary granule release from human neutrophils is potentiated by soluble fibrinogen through a mechanism depending on multiple intracellular signaling pathways","volume":"287","author":"Tuluc","year":"2004","journal-title":"Am J Physiol Cell Physiol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1007\/s00109-006-0051-7","article-title":"Fibrin(ogen) and its fragments in the pathophysiology and treatment of myocardial infarction","volume":"84","author":"Zacharowski","year":"2006","journal-title":"J Mol Med (Berl)"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.2174\/138920111798281144","article-title":"Targeting the coagulation factor fibrinogen for arthritis therapy","volume":"12","author":"Raghu","year":"2011","journal-title":"Curr Pharm Biotechnol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1172\/JCI30134","article-title":"Fibrin(ogen) exacerbates inflammatory joint disease through a mechanism linked to the integrin alphaMbeta2 binding motif","volume":"117","author":"Flick","year":"2007","journal-title":"J Clin Invest"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1021\/bi026324c","article-title":"Regulated unmasking of the cryptic binding site for integrin alpha M beta 2 in the gamma C-domain of fibrinogen","volume":"41","author":"Lishko","year":"2002","journal-title":"Biochemistry"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1002\/art.38639","article-title":"Fibrin accumulation secondary to loss of plasmin-mediated fibrinolysis drives inflammatory osteoporosis in mice","volume":"66","author":"Cole","year":"2014","journal-title":"Arthritis Rheumatol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1670731\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T06:22:56Z","timestamp":1763446976000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1670731\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,18]]},"references-count":43,"alternative-id":["10.3389\/fimmu.2025.1670731"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1670731","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,18]]},"article-number":"1670731"}}